Literature DB >> 9279316

Popliteal artery compression and force of active plantar flexion in young healthy volunteers.

U Hoffmann1, J Vetter, L Rainoni, A J Leu, A Bollinger.   

Abstract

PURPOSE: To define the prevalence of popliteal artery occlusion during active plantar flexion in normally active and highly trained young volunteers by measuring plantar flexion force and to assess the force level associated with popliteal artery occlusion.
METHODS: Eighty-four limbs of 42 healthy subjects were studied. Eighteen subjects were highly trained athletes, and 24 were normally active persons. Plantar flexion was progressively performed in prone position against a scale. Plantar flexion force was measured in kilograms. After determination of the maximum strength (Pmax) of plantar flexion force, the level necessary to occlude the popliteal artery (Poccl) was assessed by continuously monitoring that vessel using color duplex sonography.
RESULTS: Occlusion of the popliteal artery during plantar flexion was observed in 88.1% of the subjects and 77.4% of the limbs. No significant differences in prevalence were found between athletes and normally active subjects. The popliteal artery occluded at a mean plantar flexion force of 45.1 +/- 11.5 kg, which corresponded with 70.1% +/- 16.8% of the maximum force exerted during the provocation test. Poccl was not significantly different between lower limbs of athletes and nonathletes. Although in lower limbs of athletes the popliteal artery occluded at a significantly lower relative force as compared with normally active subjects (65.6% +/- 17.4% vs 74.5% +/- 17.4% of Pmax; p < 0.02), the difference was a result of two extremely low values found in a female athlete.
CONCLUSION: Positional occlusion of the popliteal artery during active plantar flexion is commonly found in young healthy volunteers. Prevalence of the phenomenon depends on the force level exerted during active plantar flexion. Popliteal artery occlusion during active plantar flexion is not more frequent in athletes and occurs at a similar force level than in normally active subjects.

Entities:  

Mesh:

Year:  1997        PMID: 9279316     DOI: 10.1016/s0741-5214(97)70190-3

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

1.  Functional popliteal artery entrapment syndrome: use of ultrasound guided Botox injection as a non-surgical treatment option.

Authors:  Matthew Hislop; Adam Brideaux; Sanjay Dhupelia
Journal:  Skeletal Radiol       Date:  2017-06-09       Impact factor: 2.199

2.  Vascular compression syndromes: a pictorial review.

Authors:  Renato Farina; Pietro Valerio Foti; Isabella Pennisi; Tiziana Vasile; Mariangela Clemenza; Giuliana La Rosa; Luca Crimi; Marco Catalano; Francesco Vacirca; Antonio Basile
Journal:  Ultrasonography       Date:  2022-02-23

3.  Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty.

Authors:  Elie Semaan; Naomi Hamburg; Wael Nasr; Palma Shaw; Robert Eberhardt; Jonathan Woodson; Gheorghe Doros; Denis Rybin; Alik Farber
Journal:  Vasc Endovascular Surg       Date:  2009-11-25       Impact factor: 1.089

4.  Popliteal Artery Entrapment Syndrome.

Authors:  Mark F. Henry; Denis C. Wilkins; Anthony W. Lambert
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

5.  Botulinum toxin A in functional popliteal entrapment syndrome: a new approach to a difficult diagnosis.

Authors:  Florin Gandor; Stephen Tisch; Anthony J Grabs; Anthony J Delaney; Lourens Bester; Paul Darveniza
Journal:  J Neural Transm (Vienna)       Date:  2014-03-25       Impact factor: 3.575

Review 6.  Functional Popliteal Artery Entrapment Syndrome: Poorly Understood and Frequently Missed? A Review of Clinical Features, Appropriate Investigations, and Treatment Options.

Authors:  Matthew Hislop; Dominic Kennedy; Brendan Cramp; Sanjay Dhupelia
Journal:  J Sports Med (Hindawi Publ Corp)       Date:  2014-09-07

7. 

Authors:  Marcelo José de Almeida
Journal:  J Vasc Bras       Date:  2016 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.